Search company, investor...

X-Cor Therapeutics

xcortherapeutics.com

Founded Year

2017

Stage

Seed VC | Alive

Total Raised

$2.8M

Last Raised

$2.6M | 2 yrs ago

About X-Cor Therapeutics

X-Cor Therapeutics develops advanced medical devices, specializing in dialysis-like carbon dioxide removal systems.

Headquarters Location

127 Western Ave

Boston, Massachusetts, 02134,

United States

Missing: X-Cor Therapeutics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: X-Cor Therapeutics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing X-Cor Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

X-Cor Therapeutics is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

8,603 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

Latest X-Cor Therapeutics News

X-Cor Therapeutics Closes $2.6M Funding Round

Nov 12, 2020

X-COR Therapeutics , an Allston, MA-based developer of a novel extracorporeal carbon dioxide removal device, closed a $2.6M seed financing. Alira Health’s investment arm, Alira Health Ventures, led the financing with syndication from Good Growth Capital, PiSA Biopharm, Flybridge Partners’ Graduate Syndicate, and other notable angel investors. The company intends to use the funds to continue developing its device toward clinical trials. Led by Jayon Wang, CEO, X-COR is a medical device company creating a carbon dioxide removal device that uses ultra-low-blood flows for the treatment for acute respiratory failure. Its novel technology is a patent-pending medical device and accompanying control algorithm that enables physicians to directly remove excess carbon dioxide from lung failure patients. FinSMEs

X-Cor Therapeutics Frequently Asked Questions (FAQ)

  • When was X-Cor Therapeutics founded?

    X-Cor Therapeutics was founded in 2017.

  • Where is X-Cor Therapeutics's headquarters?

    X-Cor Therapeutics's headquarters is located at 127 Western Ave, Boston.

  • What is X-Cor Therapeutics's latest funding round?

    X-Cor Therapeutics's latest funding round is Seed VC.

  • How much did X-Cor Therapeutics raise?

    X-Cor Therapeutics raised a total of $2.8M.

  • Who are the investors of X-Cor Therapeutics?

    Investors of X-Cor Therapeutics include The Graduate Syndicate, Good Growth Capital, Alira Health Ventures, PiSa Biopharm, Ignite Medtech and 4 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.